Close

Valeant Pharma (VRX) Receives FDA Warning Letter for Bridgewater Facility

September 30, 2014 11:31 AM EDT Send to a Friend
Valeant Pharma (NYSE: VRX) announced that the company's Bridgewater, New Jersey location received a Warning Letter from the U.S. Food ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE

Member Login